Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.
复制标题

DOI:
10.1371/journal.pone.0004724
复制
发表时间:
2009
期刊:
影响因子:
3.7
通讯作者:
Shafer RW
Shafer RW
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Bennett DE;Camacho RJ;Otelea D;Kuritzkes DR;Fleury H;Kiuchi M;Heneine W;Kantor R;Jordan MR;Schapiro JM;Vandamme AM;Sandstrom P;Boucher CA;van de Vijver D;Rhee SY;Liu TF;Pillay D;Shafer RW

文献摘要

参考文献

被引文献

相似文献

监测地方、国家和地区HIV-1耐药性传播水平的项目为治疗指南提供信息,并提供关于HIV-1治疗和预防项目成功与否的反馈。为了准确地比较不同地理区域和时间的传播耐药率,世界卫生组织建议对传播的HIV-1耐药采用共识的基因型定义。2007年1月,我们概述了制定耐药监测突变列表的标准,并编制了符合这些标准的80种RT和蛋白酶突变列表(监测耐药突变; SDRM)。自2007年1月以来,已经批准了几种新药,并发现了几种新的耐药性突变。在本文中,我们遵循先前描述的相同程序来开发可能对正在进行的和未来的传播性耐药性研究有用的SDRM的更新列表。更新的SDRM列表有93个突变,包括15个RT位置的34个NRTI耐药突变,10个RT位置的19个NNRTI耐药突变和18个蛋白酶位置的40个PI耐药突变。
Programs that monitor local, national, and regional levels of transmitted HIV-1 drug resistance inform treatment guidelines and provide feedback on the success of HIV-1 treatment and prevention programs. To accurately compare transmitted drug resistance rates across geographic regions and times, the World Health Organization has recommended the adoption of a consensus genotypic definition of transmitted HIV-1 drug resistance. In January 2007, we outlined criteria for developing a list of mutations for drug-resistance surveillance and compiled a list of 80 RT and protease mutations meeting these criteria (surveillance drug resistance mutations; SDRMs). Since January 2007, several new drugs have been approved and several new drug-resistance mutations have been identified. In this paper, we follow the same procedures described previously to develop an updated list of SDRMs that are likely to be useful for ongoing and future studies of transmitted drug resistance. The updated SDRM list has 93 mutations including 34 NRTI-resistance mutations at 15 RT positions, 19 NNRTI-resistance mutations at 10 RT positions, and 40 PI-resistance mutations at 18 protease positions.
DOI: 10.1128/aac.48.8.3122-3126.2004
发表时间: 2004-08-01
影响因子: 4.9
作者:
Rhee, SY;Liu, T;Shafer, RW
通讯作者: Shafer, RW
DOI: 10.1089/aid.2007.0317
发表时间: 2008-06-01
影响因子: 1.5
作者:
Ndembi, N.;Lyagoba, F.;Kaleebu, P.
通讯作者: Kaleebu, P.
DOI: 10.1128/jvi.00712-06
发表时间: 2006-11-01
影响因子: 5.4
作者:
Baxter, John D.;Schapiro, Jonathan M.;Mayers, Douglas L.
通讯作者: Mayers, Douglas L.
DOI: 10.1128/jvi.01547-06
发表时间: 2007-03-01
影响因子: 5.4
作者:
Mueller, Sandra M.;Schaetz, Birgit;Harrer, Thomas
通讯作者: Harrer, Thomas
DOI: 10.1093/bioinformatics/bti569
发表时间: 2005-09-01
期刊: BIOINFORMATICS
影响因子: 5.8
作者:
Myers, RE;Gale, CV;Kellam, P
通讯作者: Kellam, P